Aston Medical Research Institute, Aston Medical School, Aston University, Birmingham, United Kingdom
Aston Medical Research Institute, Aston Medical School, Aston University, Birmingham, United Kingdom.
J Am Heart Assoc. 2017 Oct 17;6(10):e007026. doi: 10.1161/JAHA.117.007026.
In cardiac resynchronization therapy (CRT), quadripolar (QUAD) left ventricular (LV) leads are less prone to postoperative complications than non-QUAD leads. Some studies have suggested better clinical outcomes.
Clinical events were assessed in 847 patients after CRT-pacing or CRT-defibrillation using either QUAD (n=287) or non-QUAD (n=560), programmed to single-site site LV pacing. Over a follow-up period of 3.2 years (median [interquartile range, 1.90-5.0]), QUAD was associated with a lower total mortality (adjusted hazard ratio [aHR]: 0.32, 95% confidence interval [CI], 0.20-0.52), cardiac mortality (aHR: 0.36, 95% CI, 0.20-0.65), and heart failure (HF) hospitalization (aHR: 0.62, 95% CI, 0.39-0.99), after adjustment for age, sex, New York Heart Association class, HF etiology, device type (CRT-pacing or CRT-defibrillation), comorbidities, atrial rhythm, medication, left ventricular ejection fraction, and creatinine. Death from pump failure was lower with QUAD (aHR: 0.33; 95% CI, 0.18-0.62), but no group differences emerged with respect to sudden cardiac death. There were no differences in implant-related complications. Re-interventions for LV displacement or phrenic nerve stimulation, which were lower with QUAD, predicted total mortality (aHR: 1.68, 95% CI, 1.11-2.54), cardiac mortality (aHR: 2.61, 95% CI, 1.66-4.11) and HF hospitalization (aHR: 2.09, 95% CI, 1.22-3.58).
CRT using QUAD, programmed to biventricular pacing with single-site LV pacing, is associated with a lower total mortality, cardiac mortality, and HF hospitalization. These trends were observed for both CRT-defibrillation and CRT-pacing, after adjustment for HF cause and other confounders. Re-intervention for LV lead displacement or phrenic nerve stimulation was associated with worse outcomes.
在心脏再同步治疗(CRT)中,与非四极(QUAD)左心室(LV)导联相比,四极(QUAD)LV 导联术后并发症发生率较低。一些研究表明其具有更好的临床结局。
在使用 QUAD(n=287)或非 QUAD(n=560)的 847 例 CRT 起搏或 CRT 除颤患者中评估临床事件,LV 起搏程控为单部位起搏。在 3.2 年的随访期间(中位数[四分位距,1.90-5.0]),QUAD 与总死亡率降低相关(校正后的危险比[aHR]:0.32,95%置信区间[CI]:0.20-0.52)、心脏死亡率(aHR:0.36,95%CI:0.20-0.65)和心力衰竭(HF)住院率(aHR:0.62,95%CI:0.39-0.99)相关,调整因素包括年龄、性别、纽约心脏协会(NYHA)心功能分级、HF 病因、器械类型(CRT 起搏或 CRT 除颤)、合并症、心房节律、药物治疗、左心室射血分数和血肌酐。QUAD 组泵衰竭死亡率较低(aHR:0.33;95%CI:0.18-0.62),但两组间心源性猝死无差异。LV 移位或膈神经刺激相关并发症无差异。LV 移位或膈神经刺激的再介入治疗较低,预测总死亡率(aHR:1.68,95%CI:1.11-2.54)、心脏死亡率(aHR:2.61,95%CI:1.66-4.11)和 HF 住院率(aHR:2.09,95%CI:1.22-3.58)。
程控为双心室起搏、单部位 LV 起搏的 CRT 使用 QUAD 与总死亡率、心脏死亡率和 HF 住院率降低相关。在调整 HF 病因和其他混杂因素后,观察到 CRT 除颤和起搏均存在这种趋势。LV 导联移位或膈神经刺激的再介入治疗与预后较差相关。